Carasent AB (publ)APXZF 80 Days Payable is 67.16 as of Mar. 2026, which is 38% below its 10-year median of 107.89. GuruFocus rates APXZF with a GF Score™ of 80/100 and a GF Value™ of $0.18. The stock has 3 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Carasent AB (publ) ranks better than 58.58% on this metric.
The historical rank and industry rank for Carasent AB (publ)'s Days Payable or its related term are showing as below:
APXZF'
s Days Payable Range Over the Past 10 Years
Min: 40.51 Med: 107.89 Max: 160.36
Current: 72.26
During the past 13 years, Carasent AB (publ)'s highest Days Payable was 160.36. The lowest was 40.51. And the median was 107.89.
APXZF's Days Payable is ranked better than 58.58% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs APXZF: 72.26
Carasent AB (publ)'s Days Payable
declined
from Mar. 2025 (103.30) to Mar. 2026 (67.16).
It may suggest that Carasent AB (publ)accelerated paying its suppliers.
Carasent AB (publ) Days Payable Related Terms
Carasent AB (publ) Days Payable Historical Data
* Premium members only.
The historical data trend for Carasent AB (publ)'s Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Carasent AB (publ)'s Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carasent AB (publ) Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Carasent AB (publ)'s Days Payable distribution charts can be found below:
* The bar in red indicates where Carasent AB (publ)'s Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Carasent AB (publ)'s Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carasent AB (publ) (APXZF) has a Days Payable of 67.16 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Carasent AB (publ) and its competitors. This is 38% below median its historical median of 107.89. Over the past decade, Carasent AB (publ)'s Days Payable has ranged from 40.51 to 160.36. According to the industry distribution chart, Carasent AB (publ) ranks #251 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 41.4%.
Is Carasent AB (publ)'s Days Payable too high?
Carasent AB (publ)'s current Days Payable of 67.16 is 38% below median its 10-year median of 107.89. Over the past 10 years, this metric has ranged from a low of 40.51 to a high of 160.36. The Healthcare Providers & Services industry median Days Payable is 58.21. Carasent AB (publ)'s value of 67.16 is 15.4% above this industry median. Based on the distribution chart, Carasent AB (publ) ranks #251 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Carasent AB (publ) has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Carasent AB (publ)'s Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Carasent AB (publ) ranks #251 out of 606 companies for Days Payable. This puts Carasent AB (publ) in the upper half of its industry. The industry median Days Payable is 58.21. Carasent AB (publ)'s value of 67.16 is 15.4% above this benchmark. Historically, Carasent AB (publ)'s own Days Payable has ranged from 40.51 to 160.36 over the past decade. While the company's 10-year median is 107.89 vs. the industry median of 58.21, Carasent AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carasent AB (publ)'s current Days Payable of 67.16 is 15.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Carasent AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carasent AB (publ)'s current Days Payable is 67.16, which is 38% below median its own 10-year median of 107.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carasent AB (publ) stock overvalued right now?
Carasent AB (publ) (APXZF) has a current Days Payable of 67.16. The stock's GF Value™ is $0.18, compared to a current price of $0.15 — trading 16.7% below its estimated fair value. The current Days Payable is 67.16, which is 38% below median its 10-year median of 107.89 and 15.4% above the Healthcare Providers & Services industry median of 58.21. Carasent AB (publ)'s overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Carasent AB (publ) (APXZF), the current Days Payable is 67.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carasent AB (publ) (APXZF) Overvalued in 2026?
Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued.
The current stock price of $0.15 is trading 16.7% below its estimated GF Value™ of $0.18.
Key valuation signals for APXZF:
Days Payable: 67.16 (38% below median its 10-year median of 107.89)
GF Value™: $0.18 vs. price of $0.15 (16.7% below fair value)
Industry Position: 15.4% above the Healthcare Providers & Services median (#251 of 606)
No single metric tells the full story. See the APXZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
80GF Score
Get the complete analysis for APXZF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
APXZF has been successfully added to your 
